Kyivstar combines profitable Ukrainian telecom infrastructure with fast-growing digital platforms and attractive cash-flow valuation, but war-related disruption, ownership uncertainty, and potential dilution create substantial downside risks.
Hold-rated reports
904 tickers rated HoldDelek US offers improving refinery cash flow and substantial logistics asset value, but volatile crack spreads, regulatory uncertainty, and uncertain through-cycle profitability constrain its investment appeal.
Emera offers dependable regulated utility earnings, a 20-year dividend-growth record and Florida infrastructure expansion, but elevated leverage, heavy capital spending and merger uncertainty limit near-term upside.
Enbridge offers durable North American energy infrastructure cash flows, attractive dividend income, and visible project-backed growth, but elevated leverage, dilution, and a demanding historical valuation limit its near-term upside.
iRhythm's differentiated cardiac monitoring platform offers long-term growth through expanding clinical adoption and improved operating leverage, but telemetry integration setbacks, regulatory exposure, and weak cash conversion threaten its recovery.
ACM Research offers strong semiconductor equipment growth through ECP, wafer cleaning, and advanced packaging expansion, but negative free cash flow, China concentration, and shareholder dilution constrain investment conviction.
Kratos is positioned to benefit from accelerating demand for affordable defense technology and record orders, but persistent cash burn, shareholder dilution, and uncertain production margins constrain its investment attractiveness.
TC Energy combines durable contracted natural gas infrastructure, rising EBITDA, and recurring dividends, but substantial leverage, capital intensity, and an already demanding valuation constrain its near-term upside.
Pembina combines durable North American energy infrastructure and attractive dividend income with growing LNG and power opportunities, but elevated historical valuation multiples and capital-intensive expansion limit its margin of safety.
Park Hotels & Resorts offers a high-dividend, asset-backed recovery opportunity through stronger hotel demand and renovation returns, but significant leverage and capital spending constrain its upside and financial flexibility.
Eagle Materials offers a resilient U.S. construction-materials franchise with meaningful recovery potential from infrastructure demand and plant modernization, but weak wallboard pricing and elevated capital spending constrain near-term returns.
Adaptive Biotechnologies offers a differentiated, rapidly expanding MRD diagnostics franchise with improving profitability, but premium valuation, reimbursement dependence, and potential dilution constrain near-term upside.